查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物医药品CMO·CRO市场:各产品类型，各来源，各服务形式，各国，各地区- 产业分析，市场规模，市场占有率，2023年～2030年预测
市场调查报告书
商品编码
1320204

生物医药品CMO·CRO市场:各产品类型，各来源，各服务形式，各国，各地区- 产业分析，市场规模，市场占有率，2023年～2030年预测

Biopharmaceutical CMO And CRO Market with COVID-19 Impact Analysis, By Product Type, Source, By Service Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 241 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年生物製药CMO/CRO市场规模为324.783亿美元，2023年至2030年复合年增长率为5.5%

生物製药 CMO/CRO 市场 - 市场动态：

生物製药产业快速成长可望带动市场需求

2020 年出现显着成长，主要是由于 COVID-19 大流行的影响。生物製药行业的知名参与者正在增加投资以提高生产力和效率，促使生物製造商将重点转向外包活动。如今，生物製药公司外包资源和资本密集流程，在某些情况下，外包整个生物製造流程。近年来，生物製药行业经历了大量的整合，主要是为了扩大业务并保持在生物製药合约製造和服务市场的竞争力。儘管生物製药 CMO/CRO 行业本身相对成熟，但新的生物加工工具、创新疗法的引入以及生物製药行业优先事项的变化正在给生物製药合约製造商带来额外的压力。因此，CDMO 正在采用各种业务模式来有效回应客户和利害关係人的需求。此外，透过将一次性系统纳入製造设施，CMO 可以经济地扩大製造能力。一次性产品可提供快速週转时间并减少清洁和转换验证等相关任务。然而，由于复杂的监管环境和服务，行销长和客户之间的合??约谈判可能会很困难。对于客户和 CMO 来说，围绕智慧财产权、保证和责任、定价和交付时间的问题进一步使这些谈判变得复杂。

生物製药 CMO/CRO 市场 - 主要见解：

  • 根据研究分析师的分析，全球生物製药 CMO/CRO 市场预计在预测期内（2023-2030 年）每年将以约 5.5% 的复合年增长率成长。
  • 由于生物製药产业的快速成长，生物製药CMO/CRO产业预计将出现高成长。
  • 按来源类型划分，预计哺乳动物将在 2022 年占最大的市场占有率
  • 从服务类型来看，合约製造将是 2022 年的主要类型。
  • 按地区划分，北美将成为 2022 年的主要收入来源。

生物製药 CMO/CRO 市场 - 区隔分析：

全球生物製药 CMO/CRO 市场按产品类型、来源、服务类型和地区区隔。

依来源类型，市场分为哺乳动物和非哺乳动物。2022年，哺乳动物区隔市场占有较大市场。这主要是由于产业内部专业知识有限，促使公司依赖哺乳动物系统，这些系统能够将类似人类的翻译后修饰引入复杂的蛋白质疗法中。除其他福利外，该区隔市场还受益于先进表达系统、改进的过程监控解决方案、细胞系工程工具、自动筛选方法和一次性设备的引入，进一步推动了其增长和成功。

市场依服务类型分为两类：合约製造与合约研究。2022年，合约製造业占最大的市场占有率。另一方面，合约研究领域预计在预测期内复合年增长率最快。这种成长的关键推动因素是生物製药公司外包其研究活动的趋势不断增加。业内有许多合约製造组织 (CMO) 和机会主义 CMO，为生物製药公司提供广泛的服务。这些服务涵盖端到端，从细胞培养到填充和精加工服务。此外，客户正在积极投资于外包其产品开发计划的製造方面。对外包的日益关注促进了研究合约领域的快速成长。

生物製药 CMO/CRO 市场 - 地理洞察：

从地理来看，该市场遍布北美、拉丁美洲、欧洲、亚太地区和中东非洲。这些地区根据其开展业务的国家进一步划分。

生物製药 CMO/CRO 市场 - 竞争格局：

生物製药CMO/CRO市场由大量现有中型、中小型CMO/CRO组成，呈现碎片化结构。这些市场进入者中有许多是私人控股公司或私募股权公司投资组合的一部分。为了提高专案吞吐量和产品质量，CMO 工厂扩大采用自动化和创新技术。因此，大分子製造商越来越有兴趣与 CMO 合作，以满足对生物製剂不断增长的需求。

最近动态

2023年3月，韩美製药将参加2023年BIO-Europe春季会议，并以CMO（合约药物製造组织）和CDMO（合约药物开发和製造组织）的身份正式启动业务活动。

研究的主要特点

  • 本研究报告提供了生物製药 CMO/CRO 市场的市场规模、复合年增长率 (CAGR%) 以及以 2022 年为基准年的估计和预测（2023-2030 年）。
  • 这份研究报告让客户深入了解生物製药 CMO/CRO 市场的最新趋势。
  • 该研究报告阐明了各个区隔市场/国家的潜在成长机会，并解释了生物製药 CMO 和 CRO 市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、现有公司面临的挑战以及维持生物製药 CMO/CRO 市场的成长因素。
  • 研究范围内详细讨论了 COVID-19 对生物製药 CMO/CRO 市场规模、预测、复合年增长率和市场动态的影响。本报告也详细介绍了新冠疫情后生物製药 CMO/CRO 市场。
  • 为了向本报告的使用者提供生物製药 CMO 和 CRO 市场的全面了解，本报告也对生物製药 CMO 和 CRO 市场的竞争格局和关键创新者进行了分析。
  • 该研究涵盖了根据市场规模、成长率和吸引力对所有行业领域进行基准测试的成长前景映射分析。
  • 主要市场参与者的详细公司简介可协助您了解在生物製药 CMO/CRO 市场中营运的公司的财务资讯和策略性举措。
  • 此外，该报告还揭示了全球和区域市场主要参与者的重要收购和併购、联盟和合资企业、新品发布、研发和区域扩张。Masu。
  • 全球生物製药 CMO/CRO 市场报告主要针对该产业的各个利害关係人，例如供应商、投资者、新进业者、经销商和财务分析师。

目录

第1章 生物医药品CMO·CRO市场概要

  • 调查范围
  • 市场估计年数

第2章 摘要整理

  • 市场明细
  • 竞争考察

第3章 生物医药品CMO·CRO的主要市场趋势

  • 生物医药品CMO·CRO推动市场要素
  • 生物医药品CMO·CRO阻碍市场要素
  • 生物医药品CMO·CRO市场机会
  • 生物医药品CMO·CRO市场未来趋势

第4章 生物医药品CMO·CRO产业的调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法规结构的分析

第5章 生物医药品CMO·CRO市场:COVID-19影响分析

  • 新型冠状病毒感染疾病前的影响分析
  • 新型冠状病毒感染疾病后的影响分析

第6章 生物医药品CMO·CRO市场形势

  • 生物医药品CMO·CRO市场占有率分析，2022年
  • 各主要製造商的明细资料
    • 确立的企业的分析
    • 新兴企业的分析

第7章 生物医药品CMO·CRO市场-各产品类型

  • 概要
    • 各产品类型市场区隔占有率分析
    • 生技药品
    • 生物相似药

第8章 生物医药品CMO·CRO市场- 各来源

  • 概要
    • 各来源市场区隔占有率分析
    • 哺乳类
    • 非哺乳类

第9章 生物医药品CMO·CRO市场- 各服务形式

  • 概要
    • 各服务形式市场区隔占有率分析
    • 受託製造
    • 受託调查

第10章 生物医药品CMO·CRO市场-各地区

  • 简介
  • 北美
    • 概要
    • 北美的生物医药品CMO·CRO的主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概要
    • 欧洲的生物医药品CMO·CRO的主要製造商
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区(APAC)
    • 概要
    • 亚太地区的生物医药品CMO·CRO的主要製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 其他
  • 南美
    • 概要
    • 南美的生物医药品CMO·CRO的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概要
    • 中东及非洲的生物医药品CMO·CRO的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第11章 主要供应商分析- 生物医药品CMO·CRO产业

  • 竞争仪表板
  • 企业简介
    • Boehringer Ingelheim GmbH
    • Lonza Group AG
    • Inno Biologics Sdn Bhd
    • Rentschler Biopharma SE
    • JRS Pharma
    • Biomeva GmbH
    • ProBioGen AG
    • Fujifilm Diosynth Biotechnologies USA, Inc.
    • Toyobo Co., Ltd.
    • Samsung Biologics
    • Thermo Fisher Scientific Inc(Patheon &PPD)
    • CMC Biologics
    • WuXi Biologics
    • AbbVie Inc.
    • Binex Co., Ltd.
    • Charles River Laboratories International, Inc.
    • ICON Plc

第12章 分析师的全方位展望

Product Code: ANV1515

REPORT HIGHLIGHT

Biopharmaceutical CMO And CRO Market size was valued at USD 32,478.3 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.

Biopharmaceutical CMO (Contract Manufacturing Organization) and CRO (Contract Research Organization) are specialized service providers within the biopharmaceutical industry that offer outsourcing solutions to biopharmaceutical companies. These CMOs have specialized facilities and expertise to manufacture a wide range of biopharmaceuticals, including biologics, vaccines, gene therapies, and other complex biological products. Biopharmaceutical CMOs play a crucial role in the production of these advanced therapeutics, as they often require sophisticated and specialized manufacturing processes. CROs on the other hand provide research and development support, conducting various phases of preclinical and clinical trials, as well as other research activities. Biopharmaceutical CROs play a critical role in advancing the drug development process by providing expertise, resources, and infrastructure for conducting clinical trials and other research studies

Biopharmaceutical CMO And CRO Market- Market Dynamics:

Rapid growth of biopharmaceutical industry is expected to propel the market demand

The year 2020 witnessed remarkable growth, primarily attributed to the impact of the COVID-19 pandemic. Prominent participants in the biopharmaceutical industry increased their investments to improve productivity and efficiency, leading bio manufacturers to shift their focus towards outsourcing activities. Currently, biopharma companies are outsourcing resource and capital-intensive steps, and in some instances, the entire biomanufacturing process, thus driving the demand for contract-based services. In recent years, the biopharmaceutical industry has experienced a significant number of consolidations, primarily driven by the aim of expanding businesses and maintaining competitiveness in the biopharmaceutical contract manufacturing and services market. While the biopharmaceutical CMO & CRO industry itself is relatively mature, the introduction of new bioprocessing tools, innovative therapeutics, and shifting priorities in the bio/pharmaceutical industry have placed additional pressure on contract biomanufacturers. Consequently, CDMOs are adopting various business models to effectively address the needs of their clients and stakeholders. Moreover, the incorporation of single-use systems in production facilities allows CMOs to economically expand their manufacturing capacity. Single-use products offer rapid turnaround times and reduce associated tasks such as cleaning and changeover validation. However, contract negotiations between CMOs and customers can be challenging due to the complexities of the regulatory landscape and services involved. Issues related to intellectual property rights, warranties & liabilities, pricing, and timelines add further complexity to these negotiations for both clients and CMOs.

Biopharmaceutical CMO And CRO Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Biopharmaceutical CMO And CRO market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)
  • The Biopharmaceutical CMO And CRO industry is projected to grow at due to rapid growth of biopharmaceutical industry
  • Based on source type, mammalian was predicted to show maximum market share in the year 2022
  • Based on service type, Contract Manufacturing was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Biopharmaceutical CMO And CRO Market- Segmentation Analysis:

The Global Biopharmaceutical CMO And CRO Market is segmented on the basis of Product Type, By Source, By Service Type, and Region.

The market is divided into two categories based on Source Type: mammalian and non- mammalian. In 2022, the mammalian segment dominated the market with a significant market share. This is mainly due to the industry's limited internal expertise, driving companies to rely on mammalian systems for their ability to introduce human-like post-translational modifications to complex protein therapeutics. Additionally, the segment has greatly benefited from the introduction of advanced expression systems, improved process monitoring solutions, cell line engineering tools, automated screening methods, and disposable devices, further bolstering its growth and success.

The market is divided into two categories based on Service type: Contract Manufacturing and Contract research. In 2022, the Contract Manufacturing segment accounted for the largest market share. On the other hand, the Contract Research segment is projected to experience the fastest CAGR during the forecast period. This growth is primarily driven by the increasing trend of biopharmaceutical companies outsourcing their research activities. Within the industry, there is a significant number of Contract Manufacturing Organizations (CMOs) and opportunistic CMOs that offer a wide array of services to biopharmaceutical entities. These services range from end-to-end coverage, starting from cell cultivation to fill/finish services. Additionally, clients are heavily investing in outsourcing the manufacturing aspect of their product development programs. This increased focus on outsourcing is contributing to the rapid growth of the Contract Research segment.

Biopharmaceutical CMO And CRO Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Biopharmaceutical CMO And CRO Market- Competitive Landscape:

The market exhibits a fragmented structure as it comprises a significant number of established and medium-to-small-sized CMOs and CROs. Many of these market participants are privately held or fall under the portfolios of private equity firms. In order to enhance project throughput and product quality, CMOs are increasingly adopting automation and innovative technologies at their facilities. As a result, large molecule manufacturers are becoming more interested in collaborating with CMOs to meet the rising demand for biologics.

Recent Developments:

In March 2023, Hanmi Pharmaceutical has announced its intention to take part in the 2023 BIO-Europe Spring Conference, where it will formally launch its CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) business activities.

Key features of the study:

  • This proposed research study on Biopharmaceutical CMO And CRO market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Biopharmaceutical CMO And CRO market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biopharmaceutical CMO And CRO market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biopharmaceutical CMO And CRO market
  • Impact of COVID-19 on Biopharmaceutical CMO And CRO market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biopharmaceutical CMO And CRO market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Biopharmaceutical CMO And CRO market, we have also included competitive landscape and key innovator analysis for the Biopharmaceutical CMO And CRO market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biopharmaceutical CMO And CRO market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Biopharmaceutical CMO And CRO market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET KEY PLAYERS

  • Boehringer Ingelheim GmbH
  • Lonza Group AG
  • Inno Biologics Sdn Bhd
  • Rentschler Biopharma SE
  • JRS Pharma
  • Biomeva GmbH
  • ProBioGen AG
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Toyobo Co., Ltd.
  • Samsung Biologics
  • Thermo Fisher Scientific Inc (Patheon & PPD)
  • CMC Biologics
  • WuXi Biologics
  • AbbVie Inc.
  • Binex Co., Ltd.
  • Charles River Laboratories International, Inc.
  • ICON Plc

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY PRODUCT TYPE

  • Biologics
  • Biosimilars

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SOURCE

  • Mammalian
  • Non-mammalian

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SERVICE TYPE

  • Contract Manufacturing
  • Contract Research

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biopharmaceutical CMO And CRO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biopharmaceutical CMO And CRO Market Snippet by Product type
    • 2.1.2. Biopharmaceutical CMO And CRO Market Snippet by Source
    • 2.1.3. Biopharmaceutical CMO And CRO Market Snippet by Service Type
    • 2.1.4. Biopharmaceutical CMO And CRO Market Snippet by Country
    • 2.1.5. Biopharmaceutical CMO And CRO Market Snippet by Region
  • 2.2. Competitive Insights

3. Biopharmaceutical CMO And CRO Key Market Trends

  • 3.1. Biopharmaceutical CMO And CRO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biopharmaceutical CMO And CRO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biopharmaceutical CMO And CRO Market Opportunities
  • 3.4. Biopharmaceutical CMO And CRO Market Future Trends

4. Biopharmaceutical CMO And CRO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biopharmaceutical CMO And CRO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biopharmaceutical CMO And CRO Market Landscape

  • 6.1. Biopharmaceutical CMO And CRO Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biopharmaceutical CMO And CRO Market - By Product type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product type, 2022 & 2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Biopharmaceutical CMO And CRO Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
    • 8.1.2. Mammalian
    • 8.1.3. Non-mammalian

9. Biopharmaceutical CMO And CRO Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2022 & 2030 (%)
    • 9.1.2. Contract Manufacturing
    • 9.1.3. Contract Research

10. Biopharmaceutical CMO And CRO Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biopharmaceutical CMO And CRO Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biopharmaceutical CMO And CRO Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biopharmaceutical CMO And CRO Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Biopharmaceutical CMO And CRO Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Biopharmaceutical CMO And CRO Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Biopharmaceutical CMO And CRO Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim GmbH
    • 11.2.2. Lonza Group AG
    • 11.2.3. Inno Biologics Sdn Bhd
    • 11.2.4. Rentschler Biopharma SE
    • 11.2.5. JRS Pharma
    • 11.2.6. Biomeva GmbH
    • 11.2.7. ProBioGen AG
    • 11.2.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
    • 11.2.9. Toyobo Co., Ltd.
    • 11.2.10. Samsung Biologics
    • 11.2.11. Thermo Fisher Scientific Inc (Patheon & PPD)
    • 11.2.12. CMC Biologics
    • 11.2.13. WuXi Biologics
    • 11.2.14. AbbVie Inc.
    • 11.2.15. Binex Co., Ltd.
    • 11.2.16. Charles River Laboratories International, Inc.
    • 11.2.17. ICON Plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biopharmaceutical CMO And CRO Market: Product type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product type
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Product type 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Source 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Service Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Service Type 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Biopharmaceutical CMO And CRO Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product type segment market share analysis, 2022 & 2030
  • FIGURE Product type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Source segment market share analysis, 2022 & 2030
  • FIGURE Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Service Type segment market share analysis, 2022 & 2030
  • FIGURE Service Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Europe Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Germany Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE India Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Brazil Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Saudi Arabia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)